Lin BioScience (ROCO:6696) Long-Term Capital Lease Obligation : NT$36.51 Mil (As of Jun. 2023)

View and export this data going back to 2018. Start your Free Trial

What is Lin BioScience Long-Term Capital Lease Obligation?

Lin BioScience's Long-Term Capital Lease Obligation for the quarter that ended in Jun. 2023 was NT$36.51 Mil.

Lin BioScience's quarterly Long-Term Capital Lease Obligation declined from Jun. 2022 (NT$36.80 Mil) to Dec. 2022 (NT$36.18 Mil) but then increased from Dec. 2022 (NT$36.18 Mil) to Jun. 2023 (NT$36.51 Mil).

Lin BioScience's annual Long-Term Capital Lease Obligation increased from Dec. 2021 (NT$0.00 Mil) to Dec. 2022 (NT$36.18 Mil) but then declined from Dec. 2022 (NT$36.18 Mil) to Dec. 2023 (NT$29.03 Mil).

Lin BioScience Long-Term Capital Lease Obligation Historical Data

The historical data trend for Lin BioScience's Long-Term Capital Lease Obligation can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

Lin BioScience Long-Term Capital Lease Obligation Chart

Lin BioScience Annual Data

Trend

Dec16

Dec17

Dec18

Dec19

Dec20

Dec21

Dec22

Dec23

Long-Term Capital Lease Obligation

Get a 7-Day Free Trial

5.15

2.24

36.18

29.03

Lin BioScience Semi-Annual Data
	Dec16	Jun17	Dec17	Jun18	Dec18	Jun19	Dec19	Jun20	Dec20	Jun21	Dec21	Jun22	Dec22	Jun23	Dec23
Long-Term Capital Lease Obligation	Get a 7-Day Free Trial										-	36.80	36.18	36.51	29.03

Lin BioScience (ROCO:6696) Long-Term Capital Lease Obligation Explanation

Long-Term Capital Lease Obligation are the amount due for long-term asset lease agreements that are nearly equivalent to asset purchases. Capital lease obligations are installment payments that constitute a payment of principal plus interest for the capital lease. The Short-Term Capital Lease Obligation is the portion of a Long-Term Capital Lease Obligation that is due over the next year.

Under US Generally Accepted Accounting Principles (GAAP), a capital lease is essentially equivalent to a purchase by the lessee if it meets the following criteria:

1. Ownership of the asset is transferred to the lessee at the end of the lease term;
2. The lease contains a bargain purchase option to buy the equipment at less than fair market value;
3. The lease term equals or exceeds 75% of the asset's estimated useful life;
4. The present value of the lease payments equals or exceeds 90% of the total original cost of the equipment.

Lin BioScience Long-Term Capital Lease Obligation Related Terms

Thank you for viewing the detailed overview of Lin BioScience's Long-Term Capital Lease Obligation provided by GuruFocus.com. Please click on the following links to see related term pages.

Lin BioScience (ROCO:6696) Business Description

Industry

GURUFOCUS.COM » STOCK LIST » Healthcare » Biotechnology » Lin BioScience Inc (ROCO:6696) » Definitions » Long-Term Capital Lease Obligation

Comparable Companies

Traded in Other Exchanges

N/A

Address

Zhongxiao East Road, 12th Floor, No. 68, Section 5, Xinyi District, Taipei City, TWN, 110

Website

https://www.linbioscience.com

Lin BioScience Inc is a drug development company. It specializes in therapies for diseases with unmet medical needs. Its novel pipeline consists of first-in-class drugs aimed at treating life-threatening or disabling diseases in oncology, ophthalmology, cardiovascular, and metabolic disease.

Lin BioScience (ROCO:6696) Headlines

No Headlines